Carcinoma, Non-small-cell Lung

Showing 1 - 25 of 574

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Worldwide (Repotrectinib, Crizotinib)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Augusta, Georgia
  • +40 more
Nov 29, 2023

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

Recruiting
  • Carcinoma, Non-small-Cell Lung
  • New York, New York
  • +1 more
Nov 8, 2023

NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Nov 7, 2023

NSCLC, Tumor Metastasis Trial in Worldwide (LY3537982, Pembrolizumab, Placebo)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Neoplasm Metastasis
  • Tucson, Arizona
  • +217 more
Nov 1, 2023

QOL After SURGERY and ADJUVANT Treatment

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Quality of Life
  • Questionnaires
  • Salamanca, Spain
    Hospital Clínico Universitario
Oct 30, 2023

Lung Cancer, Lung Tumor Malignant, NSCLC Trial in Amsterdam (Neelde Based Confocal Laser Endomicroscopy, Conventional diagnostic

Recruiting
  • Lung Cancer
  • +3 more
  • Neelde Based Confocal Laser Endomicroscopy
  • Conventional diagnostic bronchoscopy
  • Amsterdam, Netherlands
    Amsterdam University Medical Centers
Oct 6, 2023

Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Oct 4, 2023

NSCLC Trial (KB-GDT-01)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • KB-GDT-01
  • (no location specified)
Sep 29, 2023

Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Self-administered survey at hospital
  • +2 more
  • (no location specified)
Oct 3, 2023

A Multicountry, Multicentre, Non-interventional, Retrospective

Recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Kuwait, Kuwait
      Kuwait Cancer Control Center
    Sep 13, 2023

    NSCLC Trial (SGN-B6A, docetaxel)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Aug 21, 2023

    NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Aug 17, 2023

    NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Wuhan, Hubei, China
      Qian Chu
    Aug 18, 2023

    Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)

    Not yet recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • +3 more
    • disitamab vedotin
    • (no location specified)
    Aug 15, 2023

    Colorectal Tumors, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial (SGN-EGFRd2)

    Not yet recruiting
    • Colorectal Neoplasms
    • +3 more
    • (no location specified)
    Aug 1, 2023

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023

    Metabolic Response to Food in Advanced Lung Cancer

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Weight loss (%)
    • (no location specified)
    Jun 30, 2023

    NSCLC Trial in Cologne (observational, non-interventional)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • observational, non-interventional
    • Cologne, Germany
      University Hospital Cologne
    Jul 3, 2023

    NSCLC Trial in Korea, Republic of, Malaysia, United States (Cetrelimab, Amivantamab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Fairfax, Virginia
    • +3 more
    Jun 16, 2023

    NSCLC Trial in Chongqing (procedure, drug, radiation)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • bronchial artery interventional therapy
    • +3 more
    • Chongqing, Chongqing, China
      Daping Hospital, Third Military Medical University
    May 27, 2023

    NSCLC Trial in United States

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Daphne, Alabama
      • +16 more
      May 30, 2023

      China With Non-Small-Cell Lung Cancer That is Unable to be

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        May 16, 2023

        Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

        Recruiting
        • Carcinoma, Renal Cell
        • Carcinoma, Non-Small-Cell Lung
        • Live Bacterial Product - Akkermansia muciniphila
        • Mons, Belgium
        • +3 more
        May 9, 2023

        Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
          • (no location specified)
          Apr 21, 2023